
Bending Spoons
BSPNewly listed · final prospectus verifiedBending Spoons S.p.A. · Nasdaq · Consumer software · latest filing 2026/07/01
Newly listed — review valuation, deal quality and post-IPO supply before acting
Bending Spoons S.p.A. began trading on 2026-07-01 at an IPO price of $29.00; the final prospectus and offer terms are linked to SEC EDGAR.
🔒 Detailed transaction interpretation is available with Pro- Business and development direction
An acquirer and operator of global digital products and software platforms.
Current business Consumer software100%
Future development Future direction not yet disclosedNot quantified

SEC source document
The filing's first page is kept visible in the overview so the issuer, document type and filing basis can be checked before reading the analysis.
- Document
- 424B4
- Filed
- 2026/07/01
- Source
- SEC EDGAR
Three risks and three checkpoints
Valuation and future tradable supply require continued review
🔒 The evidence, figures, severity and remaining risk review are available with Pro.
- 1Goldman Sachs International——
- 2J.P. Morgan——
- 3Allen & Company LLC——
- 4Wells Fargo Securities——
- 5BofA Securities——
- 6Jefferies——
- 7Evercore ISI——
- 8BNP PARIBAS——
- 9Mizuho——
- 10Societe Generale——
- 11Crédit Agricole CIB——
- 12IMI — Intesa Sanpaolo——
- 13UniCredit——
- 14Banca Akros — Gruppo Banco BPM——
Where each offered share directs value
IPO valuation scenario simulator
Adjustable assumptions are visible after unlocking.
424B4 · 2026/07/01
- Voting
- Economic
- As of
- 2026/07/01
Next public checkpoint:First post-IPO filing and lock-up schedule
- Initial float
- Potential float
- Multiple
- Increase
Evidence completeness and operating runway
Final prospectus, offer price, listing date and headline financial evidence reconciled
Valuation and future tradable supply require continued review
- Potential impact
- Monitor
- First post-IPO filing and lock-up schedule
- Evidence
- 424B4 · 2026/07/01
- Potential impact
- Monitor
- Evidence
- 424B4 · 2026/07/01
- Potential impact
- Monitor
- Evidence
- 424B4 · 2026/07/01
Unlock each change, investor impact and evidence locator
What remains missing16% of the evidence set remains unresolved. This may affect unconfirmed pricing, valuation, dilution or supply conclusions; no missing term is estimated.
View the filing's actual first page +
